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1. Introduction 
 
 
  Basically, adaptation to the enviromental changes can be realised via reflex-
regulatory and behavioural responses. If the reflex responses are not sufficient to compensate 
the effect of the enviromental changes, then the learning processes are those which can result 
in a new, enviromental effect compensating, stable reflex-regulatory and/or behavioural 
response. The learning process can be devided into acquisition and consolidation phases. The 
former means the response formation, while the latter is the stabilization of responses. In the 
present experiments we focused mainly on the investigation of the consolidation processes.  
  The dopamine (DA) is one of the most important neurotransmitters and 
neuromodulators in the central nervous system.  The main sources of DA in the brain are the 
mesolimbic, mesocortical and nigrostriatal DA-ergic pathways originating from the DA-ergic 
neurons of the ventral tegmental area (VTA), substantia nigra (SN) and retrorubral area.  
According to our present knowledge five different DA receptors are known (D1-5), which can 
be grouped in two major families (i.e. D1-subtype and D2-subtype, respectively) [1]. In 
different brain regions the role of DA and its receptors has been confirmed in motor-
regulation [2, 3], motivation [3-6], attentional and perceptual processes [3, 5, 7], furthermore 
rewarding effect of DA has been demonstrated [8-10]. Besides these processes DA has an 
outstanding importance in learning and memory. Based on the firing pattern of the 
mesencephalic DA-ergic neurons the phasic activity reflects the prediction error between the 
actual and the expected reward, thereby forming the biological signal of learning [11]. The 
role of DA in learning processes has been proven in various brain regions, in different 
behavioural paradigms. [12-20]. The role of DA in memory formation has been confirmed not 
only on the behavioural level, but on the structural level as well. It has been shown in 
numerous brain regions that DA receptors are necessary for the formation of the long term 
potentitation (LTP) and long term depression (LTD) which are the electrophysiological 
correlates of synaptic plasticity. The activation of the D1 DA receptors plays an important 
role in the hippocampal (HPC) LTP formation [12], and modulates it in the striatum and in 
the prefrontal cortex (PFC) [21, 22]. In the striatum both the D1 and the D2 DA receptor 
activation are necessary for the formation of LTP and LTD [23]. 
The venral pallidum (VP) is a basal forebrain structure which was originally 
described by Heimer and Wilson in 1975 as the ventral, subcommissural extension of the 
globus pallidus [24]. The VP is in connection with several brain regions involved in learning 
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processes such as the nucleus accumbens (NAC) [25, 26], the amygdala (AMY) [27] or the 
PFC [28, 29]. The VP is in reciprocal connection with the mesencephalic DA-ergic  nuclei, its 
DA-ergic afferentation is originating mostly from the VTA and to a lesser extent from the SN 
[30]. In the VP both D1 and D2 DA receptor subtypes have been detected using 
autoradiography [31, 32] and immunohistochemistry [33, 34]. The role of the ventral pallidal 
DA is known in motor and motivational processes, and its role can be supposed in positive 
reinforcement (reward) as well. It has been shown that electrical self-stimulation can be 
developed in the VP [35], and it can be attenuated by the systemic application of DA 
antagonists [36]. The amphetamine induced place preference (acquisition) can be prevented 
by the excitotoxic lesion of the VP, however, the already formed place preference is not 
affected by it [37]. Place preference can be induced by the administration of the indirect DA 
agonists cocaine or amphetamine into the VP  [38]. The formation of the cocaine-induced 
place preference can be blocked by 6-hidroxidopamine (6-OHDA) lesion of the VP [39]. It 
has been demonstrated that cocaine remarkably increases the DA level in the VP [39]. 
 
2. Objectives 
 
  Based on the above information, DA has a key role in learning, and especially in the 
consolidation processes as it was confirmed in the PFC, AMY, dorsal striatum (CPU),  HPC 
and NAC as well. All of these brain areas have connections directly or indirectly with the VP, 
which is densely innervated by the DA-ergic neurons of the VTA, mainly via the fibers of the 
MLDR. In the VP both D1 and D2 DA receptor subtypes can be found. Until now these 
receptors have been investigated only in the regulation of motor/locomotor activity and in 
certain motivational processes, however, less is known about their role in learning and 
memory processes. In our present experiments we strove to clarify the role of the VP DA 
receptors in memory consolidation and in the stability of the formed memory, and therefore, 
the following experiments were performed:  
1. In Morris water maze test effects of DA agonists on spatial learnig related memory 
consolidation and on stability of the formed memory against extinction were investigated 
with:  
a) the D1 DA receptor agonist SKF38393 and 
b) the D2 DA receptor agonist Quinpirole 
microinjected into the VP. 
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2. In one-trial inhibitory avoidance paradigm effects of DA agonists on negative 
reinforcement related memory consolidation and on long-term stability of the formed 
memory were investigated with: 
a) the D1 DA receptor agonist SKF38393 and 
b) the D2 DA receptor agonist Quinpirole 
microinjected into the VP. 
3. In both paradigms selective DA receptor antagonists were used to confirm that the effects 
of D1 DA receptor agonist SKF38393 were mediated via the D1 DA receptors, while the 
effects of D2 DA receptor agonist Quinpirole were the consequence of D2 DA receptor 
activation. In the former case the D1 selective SCH23390, while in the latter the D2 
selective Sulpiride was applied.  
4. The basic condition of the investigation of memory consolidation is that short-term 
memory has to be formed in the experimental animals, which can be stabilised in the long 
run in the nervous system via the memory consolidation processes. In the Morris water 
maze test the formation of the short-term memory could be observed after one trial due to 
the schedule of the experiment, however in the one-trial inhibitory avoidance task a 
separate experiment was planned to demonstrate the development of short-term memory.  
5. It is well-known that the indirect DA agonist cocaine and amphetamine  microinjected 
into the VP can induce place preference, however, little information is available about the 
DA or its direct agonist. For the better interpretation of our experimental results, it was 
important to clarify whether the applied agonists have direct rewarding or punishing 
effects besides the memory consolidation influencing impact. Therefore, effects of both 
agonists were investigated in conditioned place preference test. 
 
3. Materials and methods 
 
3.1. Subjects 
 
  In our experiments 430 male Wistar rats weighing 280–320 g at the beginning of the 
experiments were used (LATI, Gödöllő). Animals were kept in a light and temperature 
controlled room (12:12 h light–dark cyclewith lights on at 06:00 a.m., 22 ± 2◦C).  Tap water 
and standard laboratory food pellets (CRLT/N standard rodent food pellet, CharlesRiver 
Laboratories, Budapest) were available ad libitum. Food and water consumption and body 
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weight were measured daily. During the microinjections, awake, well-handled rats were 
gently held in hand. Rats were housed individually and cared for in accordance with 
institutional (BA02/2000-8/2012), national (Hungarian Government Decree,40/2013. II. 14) 
and international standards (European Community Council Directive,86/609/EEC, 1986, 
2010).  
 
3.2. Surgery 
 
  By means of stereotaxic technique stainless steel bilateral guide tubes (22 gauge 
diameter, 0.64 mm) were stereotaxically implanted 0.5 mm above the VP. Coordinates of the 
target structure relative to the Bregma (the crossing point of the sutura coronalis and 
saggittalis) were ML.: ± 2.2 mm, AP.: - 0.26 mm DV.: - 7.1 mm according to the stereotaxic 
atlas of Paxinos and Watson [40].  
 
3.3. Materials  
 
  In our experiments the D1 DA receptor agonist SKF38393 (Sigma-Aldrich Co.: R-
(+)-SKF-38393 hydrochloride, S101, molecular weight 291.77 g/mol) was applied in three 
different doses: 0.1 g (0.85 mM), 1.0 g (8.56 mM) and 5.0 g (42.84 mM), as well as the  
D2 DA receptor agonist Quinpirole (Sigma-Aldrich Co.: Quinpirole hydrochlride, Q102, 
molecular weight 255.79 g/mol) in three different doses: 0.1 g (0.98 mM), 1.0 g (9.77 mM) 
and 5.0 g (48.89 mM) . Both agonists were dissolved in physiological saline (vehicle). 
Control animals received the vehicle in equal volume to that used for the agonist 
microinjections.  
The 5.0 g (38.55 mM) dose of the selective D1 DA receptor antagonist SCH23393 
(Sigma-Aldrich Co.: (R)-(+)-SCH-23390 hydrochloride, D054, molecular weight 324.24 
g/mol) was used to investigate the specificity of the D1 DA receptor agonist SKF38393, while 
4.0 g (29.29 mM) or 0.4 g (2.93 mM)  dose of the D2 DA receptor antagonist Sulpiride 
(Sigma-Aldrich Co.: (S)-(-)-Sulpiride, S7771, molecular weight 341.43  g/mol) was applied to 
investigate the specificity of the D2 DA receptor agonist Quinpirole. Antagonists were 
dissolved in physiological saline (vehicle), and this vehicle solution was microinjected to the 
animlas of the corresponding control group in equal volume to that used for the antagonist 
microinjections. In all cases the drugs were microinjected bilaterally in a volume of 0.4 μl into 
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the target area. The antagonists or vehicle were microinjected 15 minutes prior to the 
administration of the agonist or vehicle.  All microinjections were delivered into the target 
area by Hamilton syringe and  Cole-Parmer programmable perfusion pump. 
 
3.4. Behavioural experiments 
 
  Behavioural tests were carried out in sound-proofed and air-conditioned 
(temperature: 22±2  °C) experimental rooms. Behaviour of animals was recorded by a video 
camera and recorder, furthermore data analysis was made by means of EthoVision Basic 
software (Noldus Information Technology B.V., Wageningen, The Netherlands). 
 
3.4.1.  Morris water maze test 
 
The Morris water maze test is applied to investigate the spatial learnig and memory 
processes. In the experiments a circular pool (1.5 meter in diameter and 60 cm in height)l was 
filled with water (23±1 °C)  up to 40 cm. The circular pool was devided virtually into four 
quadrants, from which in one quadrant (the target quadrant) a transparent plastic platform was 
placed under the level of the water with 2 cm. The place of the platform was constant 
throughout the whole experiment. Water was coloured with methylene blue to prevent the 
visibility of the platform for the rats. Rats were placed into the water maze at randomly 
assigned but predetermined locations. The pool was surrounded with simple black and white 
geometric shapes representing external cues, which helped the orientation of the animals.  
One day before the start of training (0. day), rats were habituated to the pool by 
allowing them to perform swimming for 90 sec without platform. During the habituation the 
distanced moved by the rats was measured. Thereafter the animals were divided into four 
groups in a way that the groups had similar means concerning the distance moved. In the 
morning of the first day, after the replacement of the platform, two trials for spatial learning 
were performed, the two trials were separated by one minute interval (first and second 
conditioning trial). This was followed by the microinjection of the solutions. The short 
intertrial interval ensured the possibility to observe in the second trial the short-term memory 
formed during the first trial. In the morning of the second day the schedule of the first day 
was repeated, rats were placed into the water maze for two trials (third and fouth 
conditioning) with one minute intertrial interval, and the second trial was immediately 
followed by the microinjections. During the conditionings (conditioning 1.-4.) the latency to 
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find the hidden platform (escape latency) was measured. Rats remained in the pool as long as 
they found the platform. After finding the platform, the rats were allowed to remain there for 
60 s to map the enviroment. Animals failing to find the platform in 180 sec, were placed on 
the platform and were allowed to rest for 60 sec. In the morning of the third day the platform 
was removed (extinction or trial without platform), and animals were allowed to swim for 180 
sec. In this trial the latency to the first crossing of the removed platform’s place was 
measured. In addition to the first crossing, three other parameters were measured: the time 
spent in the target quadrant, the number of the entries into the target quadrant (where the 
platform was previously placed) and number of crossings at the place of the removed hidden 
platform. Obviously, the increased preference for the place of the platform and its 
environment can be reflected, but only weakly, by the first two parameters compared to the 
latter one. In the afternoon of the third day, the test trial was carried out: the platform was 
replaced and the latency to finding the safe platform was measured again. During the 
experiments, in each trial the mean swimming velocities of the animals were measured. 
 
3.4.2. Inhibitory avoidance test 
 
As a classic learning model for negative reinforcement, the one trial step-through 
inhibitory avoidance paradigm was used. The experimental apparatus consisted of a large 
(60×60×60 cm), square based, well illuminated chamber with light-gray walls and attached to 
a small box (15×15×15 cm) equipped with a removable roof, painted black, and having metal-
grid floor for the delivery of electrical shocks. The two compartments (the small black and the 
big gray) were separated by a guillotine door. In each trial the rats were placed in the center of 
the larger well illuminated chamber, and the latency of entering the dark box - called step-
through latency- was recorded. Each trial lasted maximum 180 sec. 
Prior to the conditioning, the rats were habituated to the experimental apparatus (0. 
day), during which they were allowed to explore the whole apparatus. In this trial the latency 
of the first entering to the dark box was measured. After habituation the animals were divided 
into four groups having similar means of step-through latency. In the conditioning trial the 
rats were placed into the large illuminated chamber and after entering the dark compartment 
the door was closed and an unescapable electric foot shock (0.5 mA, 1 sec) was applied 
through the floor grid 3 times. The conditioning trial was immedialtely followed by the 
microinjections. The tests were performed 24 hours (2. day), 1 week (8. day) and 2 weeks (15. 
days) after conditioning (Test 1, Test 2, Test 3; respectively). During the tests animals did not 
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receive any shock or microinjection after entering the dark compartment. In the habituation 
the measurement was terminated after 180 sec, and in the conditioning and in the test trials if 
the animal fully entered with its four extremities into the dark chamber or if the 180 sec has 
elapsed.  
To demonstrate the formation of the short-term memory in case of the inhibitory 
avoidance paradigm an additional experiment was performed. Animals were habituated to the 
apparatus similarly to the above experiments. After the habituation animals were divided in 
two groups. In case of both groups the experiment was similarly performed like in the above 
experiments up to the shocking. After the shocking the animals of the first group were 
microinjected with physiological saline into the VP (this group was similar to the simple 
control group), while the animals of the second group were replaced into the apparatus after 1 
minute (replaced controls), and the step-through latencies were measured (test after 1 minute). 
Thereafter the replaced animals were also microinjected with physiological saline. After 24 
hours both groups were tested (corresponding to the Test 1). 
  
3.4.3. Place preference test 
 
The place preference paradigm is applied to investigate the positive or negative 
reinforcing (rewarding or punishing) effects of different chemical substances. The open field-
based place preference test used in our experiments corrensponds to that elaborated by 
Hasenohrl and Huston [41]. Our corral apparatus consisted of a circular open field, with a 
diameter of 85 cm and 40 cm high wall. Black lines divided the floor into four quadrants of 
equal size. External visual cues in the surroundings helped the animals’ spatial orientation 
inside the apparatus and these were in constant position during the experiments. 
The place preference test was performed for four consecutive days. The first day of the 
experiments animals were habituated, all animals were placed in the center of the apparatus. 
Thereafter the rats had free access to all parts of the apparatus for 900 sec. During the 
habituation the distance moved by the rats, the time spent in the treatment quadrant and the 
number of entries into the quadrants were measured. Before the administration of the drugs 
neither preference nor aversion were observed in the animals, i.e. significant differences were 
not found among the times spent in the different quadrants. Treatment quadrant (target 
quadrant) was determined to be one of the four quadrants in which the animal had spent 
neither the longest nor the shortest time during habituation.  After the habituation the animals 
were divided into four groups based on the time spent in the quadrants in a way that the 
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groups had similar means.  The distribution of the treatment quadrants was balanced within 
each groups, the animals were randomly assigned to the different groups. During conditioning 
trials the quadrants were physically separated by each other by means of a plexiglass barrier.  
After the drug microinjections animals were placed into the treatment quadrant. The rats were 
restricted to the treatment quadrant for 15 minutes, during this time the rats could associate 
the effect induced by the drug to the treatment quadrant. The animals could see the external 
visual cues during conditioning, which facilitated their orientation. Both conditioning days the 
same process was applied.  On the fourth day the plexi barrier has been removed. The animals 
were placed in the center of the apparatus, and they had free access to all parts of the 
apparatus for 15 minutes. During the test the time spent in the each quadrants - including in 
the treatment quadrant -, distance moved and the number of entries into the quadrants - 
including into the treatment quadrant – were measured.   
 
3.5. Data analysis 
 
3.5.1. Statistics 
 
  Data were evaluated by one-way and two-way ANOVA, or by paired t-test using the 
SPSS data analysis program (SPSS 20.0 for Windows). To check the homogeneity of the 
samples F-test was applied. Comparison of the groups was carried out with Tukey post hoc 
analysis. Statistical significance was established at p < 0.05.  
 
3.5.2. Histology 
 
  At the end of the experiments animals were anaesthetised with 20% solution of 
urethane and were perfused transcardially with physiological saline followed by 10% 
formalin solution. Brains were sliced with a freezing microtome in 40 μm sections. Sections 
were stained with cresyl violet, and the injection sites were reconstructed by means of light 
microscope and according to a stereotaxic atlas [40]. Animals with incorrect cannula 
placements were excluded from the statistical evaluation. 
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4. Results 
 
4.1. Histological results  
 
  Histological examination showed that the cannulae were precisely and symmetrically 
tipped into the target area (i.e. VP) in 382 of the altogether 430 rats, while the cannulae of the 
remaining rats were mistargetted (n = 40) or their acrylate “headpiece” was damaged or came 
off (n = 8). The rats with incorrect cannula position or damaged “headpiece” were excluded 
from the statistical analysis. 
 
4.2. Results of the Morris water maze test  
 
4.2.1. Effects of activation of the D1 dopamine receptor  
 
Effects of  SKF38393 treatment: 
 
  In this experiment effect of the D1 DA receptor agonist SKF38393 treatment on 
escape latency was investigated in Morris water maze test. Our results showed that there was 
no significant difference among the groups in the first two conditioning trials. In the first 
conditioning trial the rats found randomly the hidden platform, correspondingly their latency 
was a relatively high value. However, one minute after the first conditioning trial, in the 
second conditioning trial, all groups found significantly faster the platform compared to the 
first conditioning trial, i.e. their escape latencies significantly decreased. These findings 
confirmed the formation of the short-term memory. The second conditioning was immediately 
followed by the first microinjection of the solutions. After 24 hours the results of the third 
conditioning trial indicated that the 0.1 and 1.0 µg agonist treated groups could recall the 
place of the platform which was already learned in the previous day, while the control and 
the 5.0 µg agonist treated groups - although their escape latencies were somewhat reduced 
relative to that of the first conditioning - almost completely forgot it. In the fourth 
conditioning trial, one minute after the third conditioning trial, repeatedly all groups found the 
platform signinficantly faster compared to the first conditioning trial. In the morning of the 
third day, in the trial without the platform (which was an extinction trial as well) latencies of 
all groups were significantly shorter relative to the first conditioning trial. After the platform 
was replaced, in the test trial there was a significant difference again among the groups: the 
11 
 
0.1 and 1.0 µg agonist treated groups found significantly faster the hidden platform compared 
to the control group whose escape latency was similar to that measured on the third 
conditioning trial. 
  In the extinction trial - in addition to the first crossing of the removed platform’s 
place - the number of entries into the target quadrant (where the platform was previously 
placed), the time spent in the target quadrant and the number of crossings at the place of the 
removed hidden platform were measured. Comparision of the means showed that there was 
no significant difference among groups in any parameter.    
  In all trials the mean velocities of the animals were measured. Significant differences 
were not revealed by statistical analysis in any trial.   
 
Effects of SCH23390 treatment: 
 
  In order to clarify whether the effect of the D1 DA receptor agonist SKF38393 was 
specific to the D1 DA receptors, the selective D1 DA receptor antagonist SCH23390 was 
applied.  
  Our results demonstrated that the effects of the agonist were mediated via the D1 DA 
receptors, since the antagonist pretreatment eliminated the effects of the 1.0 µg agonist 
treatment: animals of the antagonist + agonist treated group behaved similarly to that of the 
control group, their latencies did not differ significantly from that of the control animals in 
any trial.  Effect of the antagonist applied by itself was similar to that of the vehicle, although, 
escape latencies of the antagonist treated animals were sligly shorter compared to those of 
controls in the third conditioning trial and in the test trial when the platform was re-placed.  
  In the extinction trial the number of entries into the target quadrant, the time spent in 
the target quadrant and the number of crossings at the place of the removed hidden platform 
were measured. The means of the antagonist treated group proved to be significantly shorter 
to the means of the 1.0 µg agonist treated group in case of all the parameters, while to the 
means of the control group only in the time spent in the target quadrant.     
There were no significant differences among the mean velocities of the groups in any 
trial.  
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4.2.2. Effects of activation of the D2 dopamine receptors  
 
Efects of Quinpirole treatment: 
 
  In this experiment effect of the D2 DA receptor agonist Quinpirole treatment on 
escape latencies of the rats was investigated in Morris water maze test. In case of all groups 
the formation of the short-term memory was confirmed by the results of the first two 
conditioning trials similar to the experiments with the D1 DA agonist. The second 
conditioning was immediately followed by the first microinjection of the solutions. After 24 
hours the results of the third conditioning trial indicated that the 1.0 and 5.0 µg agonist 
treated groups could recall the place of the platform which was already learned in the 
previous day, while the means of the controls and of the 0.1 µg agonist treated group - 
although their escape latencies were somewhat reduced relative to that of the first 
conditioning - statistically were similar to those of the first conditioning trial. In the fourth 
conditioning trial and in the extinction trial there were no significant differences among the 
groups, all of those found the platform or the place of the removed platform significantly 
faster compared to the first conditioning trial. When the platform was replaced the 1.0 and 5.0 
µg agonist treated groups found the platform with a significantly shorter latency than the 
control group, whose escape latencies were similar to the results of the third conditioning 
trial.   
  In the extinction trial - in addition to the first crossing of the removed platform’s 
place - the number of entries into the target quadrant (where the platform was previously 
placed), the time spent in the target quadrant and the number of crossings at the place of the 
removed hidden platform were measured. Comparision of the means showed that there were 
no significant differences among groups in any parameter.    
  In all trials the mean velocities of the animals were measured. Significant differences 
were not revealed by statistical analysis in any trial.   
 
Effects of Sulpiride treatment: 
 
  The D2 DA receptor antagonist Sulpiride was applied to clarify whether the effects 
induced by the Quinpirole developed via the acivation the D2 DA receptors. Our results 
demonstrated that the agonist had its effect through the D2 DA receptors, because the 
antagonist pretreatment eliminated the effects of the 1.0 µg agonist treatment. Means of the 
antagonist + agonist treated group did not differ significantly from those of the control group 
in the third conditioning trial and in the test trial when the platform was replaced. The 
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formation of the short-term memory in the first two conditioning trials was demonstrated in 
these experiments as well. Important finding was that the microinjection of the antagonist + 
agonist or the antagonist by itself immediately after the second conditioning trial impaired 
the learning functions, which was confirmed by the fact that the latencies of these groups after 
the second conditioning trial were not significantly different from the latencies of the first 
conditioning trial.   
  In the trial without the platform (extinction trial) in addition to the first crossing of 
the removed platform’s place other parameters were measured as well (see above). The results 
of the analysis revealed that the mean of the antagonist + agonist treated group was 
significantly lower compared to those of the controls and the 1.0 µg agonist treated group 
considering the number of crossings at the place of the removed platform. 
  The mean velocities of the groups were compared statistically to each other in each 
trial: significant differences were not revealed. 
 
4.3. Results of the inhibitory avoidance test 
 
4.3.1. Effects of activation of the D1 dopamine receptors  
 
Effects of  SKF38393 treatment: 
 
  The effect of the different doses of the D1 DA receptor agonist SKF38393 on step-
through latency was investigated in inhibitory avoidance test. In the conditioning trial 
significant difference was not found among the groups. 24 hours after the conditioning trial, 
in the first test latencies of the 1.0 µg and 5.0 µg agonist treated groups were significantly 
longer relative to that of the control group, furthermore both doses of the agonist enhanced 
the retention one and two weeks (i.e. in the second and in the third test)  after conditioning.   
 
Effects of SCH23390 treatment: 
 
  The selective D1 DA receptor antagonist SCH23390 was used to clarify whether the 
effect of the SKF38393 developed via the D1 DA receptors. The antagonist was applied 15 
minutes prior to the agonist treatment or by itself. Based on the statistical analysis within each 
trial, in the conditioning trial there was no significant difference among the groups. On the 
other hand, the 1.0 µg dose of the agonist increased the step-through latency compared to the 
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latencies of all other groups in the first, in the second and in the third test trial, as well. These 
findings confirmed the effects of SKF38393 were mediated via D1 DA receptors.  
 
4.3.2. Effects of activation of the D2 dopamine receptors 
 
Effects of Quinpirole treatment: 
 
  The effect of the D2 DA receptor agonist Quinpirole was investigated on the step-
through latency of the rats. In the conditioning trial there was no significant difference among 
the groups. 24 hours after the conditioning trial, in the first test the 0.1 µg agonist treatment 
increased significantly the step-through latency compared to the control, the  1.0 µg and the 
5.0 µg agonist treated groups. Moreover the 0.1 µg dose of the agonist enhanced the retention 
one and two weeks after conditioning.  
 
Effects of Sulpiride treatment: 
 
  Based on the results of the experiments with the D2 DA receptor agonist Quinpirole, 
the D2 DA receptor antagonist Sulpiride was applied to reveal the receptor specificity of the 
Quinpirole’s effects. The analysis within the trials demonstrated that the 0.1 µg dose of the D2 
DA agonist increased the step-through latency in the first and second test compared to the 
control, the  antagonist + agonist and the antagonist treated groups. However, in the third 
test the 0.1 µg dose of the agonist increased latency compared only to the control and the 
antagonist + agonist treated groups. In summary our findings proved that the effects of the 
Quinpirole were mediated via the activation of the D2 DA receptors. 
 
4.3.3. Verification of the formation of the short-term memory in inhibitory avoidance 
paradigm  
 
  Akin to the Morris water maze paradigm, in the inhibitory avoidance paradigm it was 
also necessary to demonstrate the formation of the short-term memory whose consolidation 
could be enhanced by the appropriate doses of the agonists. In this experiment to confirm the 
short-term memory formation, two physiological saline treated groups were applied: one 
group was replaced into the apparatus only 24 hours after the conditioning, while the other 
group - similarly to the schedule of the Morris water maze paradigm - was replaced one 
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minute and 24 hours (corresponding to the first test) after the conditioning. The means of the 
single sessions were compared to each other within both groups. In case of the first group 
(replaced once) there was no significant difference between the means of the conditioning 
trial and the first test (after 24 hours). In case of the second group (replaced twice) the 
animals entered into the dark compartment significantly earlier relative to the conditioning 
trial, however after 24 hours, in the test trial they behaved as in the conditioning trial. These 
findings proved the formation of the short-term memory in the inhibitory avoidance 
paradigm.  
 
4.4. Results of the place preference test  
 
4.4.1. Effects of SKF38393 treatment in place preference test  
 
  Effect of the D1 DA receptor agonist SKF38393 on the time spent in the treatment 
quadrant was investigated in conditioned place preference paradigm. Significant differences 
were not revealed among the groups by the statistical analysis within the trials.   
  In addition to the time spent in the treatment quadrant, the distance moved, the 
number of entries into the treatment quadrant and the percentage between the number of 
entries into the treatment quadrant and into the all quadrants (included the treatment quadrant) 
were measured. Significant differences were not revealed among the groups in the habituation 
or in the test session.  
 
4.4.2. Effects of Quinpirole treatment in place preference test  
 
  Effect of the D2 DA receptor agonist Quinpirole on the time spent in the treatment 
quadrant was investigated in conditioned place preference paradigm. Significant differences 
were not revealed among the groups by the statistical analysis within the trials.   
  In addition to the time spent in the treatment quadrant, the distance moved, the 
number of entries into the treatment quadrant and the percentage between the number of 
entries into the treatment quadrant and into the all different quadrants were measured. 
Significant difference was not revealed among the groups in the habituation session. However 
in the test session the 1.0 µg D2 agonist Quinpirole treatment significantly increased the 
distance moved and the number of entries into the treatment quadrant compared to the 
controls and the 0.1 µg agonist treated groups. Considering the ratio (percentual evaluation) 
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between the number of entries into the treatment quadrant and into the all different quadrants, 
there was no statistical difference among the groups in the test session.  
 
5. Discussion 
 
5.1. Evaluation of the results of the Morris water maze test 
 
The Morris wate maze test is a widely used method to investigate the spatial learning 
and memory processes [42-44]. In our swimming experiments the formation of short-term 
memory was confirmed. According to our interpretation the differences among the groups 
during the third conditioning trial could be due to the memory consolidation enhancing effect 
of the 0.1 µg and 1.0 µg D1 DA receptor agonist SKF38393, as well as, of the 1.0 µg and 5.0 
µg D2 DA receptor agonist Quinpirole. This is supported by the fact that the latencies of these 
groups were very similar to those of the second conditioning trial, i.e. the short-term memory 
has been consolidated by the effective doses of the agonists. The second microinjection of the 
agonists did not affect significantly the consolidation processes.   
The role of the D1 and D2 DA receptors in memory consolidation has been 
confirmed  in the NAC [13, 45], the HPC [46-48] and in the AMY [18, 46] by means of direct 
and indirect DA agonist, as well as by DA antagonist. Further evidences are provided by 
genetical manipulations and chemical lesions: in genetically modified D1 DA receptor 
deficient mouse spatial learning deficiency can be observed [12, 49], furthermore the 6-
OHDA  lesion of the HPC and the NAC shell region can result in learning disturbances in 
Morris water maze test [50, 51]. Interestingly, the 6-OHDA lesion of the CPU impairs the 
spatial, i.e. allocentric learning besides the egocentric one [52], which is contradictory to 
other findigs showing that DA release in the dorsal striatum does not play an essential role in 
spatial learning [18, 46, 48]. One reason of the latter result can be that the lesion was 
performed before the conditioning, which could influence not only the consolidation 
processes, but the acquisition or motivational processes as well. Another possible explanation 
is that in the absence of the DMI pretreatment the 6-OHDA lesion affected not only the DA-
ergic, but also the noradrenergic terminal elements [52].  
An additional important finding is provided by our experiments. In the third day 
morning the platform was removed, i.e. an extinction was performed with the experimental 
animals. The same day, afternoon, the platform was replaced to investigate the effect of the 
17 
 
previous/morning extinction on memory. Results of the test confirmed that the 0.1 µg and 1.0 
µg SKF38393 as well as the 1.0 µg and 5.0 µg Quinpirole significantly decreased the 
latencies to find the platform compared to the control group. There are several possible 
explanations of the observed phenomenon.  On the one hand (and we prefer this explanation), 
the effective doses of the agonists increase the stability of the formed memory against 
extinction. On the other hand, the differences observed during the test can be due to 
perseverative behaviour of the rats evoked by that certain doses of the agonists. This latter 
alternative has to be considered because it is supported by several experimental data. Namely, 
the stimulation of the DA receptors reduces behavioural flexibility, impairs strategy changing 
ability and increases the number of perseverative responses [53-56]. Consequently, it cannot 
be excluded that DA receptors of the VP may play a role in the induction of perseverative 
behaviour. In order to clarify this question, in the extinction trial - in addition to the latency to 
the first crossing of the removed platform’s place - the number of entries into the target 
quadrant, the time spent in the target quadrant and the number of crossings at the place of the 
removed hidden platform were measured. Neither in case of the experiments with D1, nor 
with the D2 DA receptor agonist was significant difference among groups analysing any of 
these parameters. Both the control and the agonist treated groups (including the non effective 
doses) searched the platform at its original place, than - after not finding it there - they started 
to follow the general searching strategy.  The results of the extinction trial support the view of 
that the attractive characteristic of the platform’s place is not reduced by one extinction trial, 
but the stability of the memory related to the place decreases. This latter means that during the 
test trial it is more difficult to find the platform for the control rat compared to the animal 
treated with the effective dose. Based on these findings our original hypothesis concerning 
that both agonists increase the memory stability can be maintained.  
The D1 DA receptor antagonist SCH23390 and the D2 DA receptor antagonist 
Sulpiride pretreatment proved that the SKF38393 activated the D1 DA receptors, while the 
Quinpirole the D2 DA receptors. The SCH23390 applied by itself  did not influence 
significantly the learning processes, but the extinction was somewhat enhanced. To prove this 
latter, further experiments are required, however. In contrast to the effect of the D1 DA 
antagonist the Sulpiride applied by itself or in combination with the agonist resulted in that 
these animals found relatively slowly, or they did not found the hidden platform after the 
second conditioning trial. This effect of the antagonist is probably due to the general and 
long-term impairment of learning processes. It is well known that D2 DA antagonists may 
have an extinction-like effect, i.e. to their effects the motivational value of the reward, reward 
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related signals and actions decreases [57-60]. Therefore, it was important to exclude that the 
antagonist treatment influenced permanently the motivational processes of the animals.  
During the trial, when the platform was removed, the searching behaviour of the antagonist 
treated rats was very similar to those of controls, however the former animals found the 
platform slower than the latters. This confirmed that the antagonist does not influence the 
motivational processes, but impairs the learning of the animals.  
The role of D2 DA receptors in consolidation processes is supported by other 
experimental findigs as well, which have demonstrated that the D2 DA receptors of the NAC 
(the main input structure of the VP) and of the HPC are necessary for the consolidation 
processes of the spatial learning [13, 45, 48].  
We can conclude that the activation of the VP D1 and D2 DA receptors accelerates 
the memory consolidation in spatial learning, and increases the stability of the formed 
memory against extinction. Furthermore, activation of the VP D2 DA receptors is the 
necessary condition of these processes, the block of these receptors leads to the general 
imparment of the spatial learning processes. 
 
5.2. Evaluation of the results of the inhibitory avoidance test  
 
 
The inhibitory avoidance test is a widely used paradigm to investigate the negative 
reinforcement (punishment-learning).  In our experiments the D1 DA receptor agonist 
SKF38393 dose-dependently, furthermore, the D2 DA receptor agonist in 0.1 µg dose proved 
to be effective, that is improved learning and the retention. In a separate experiment it was 
demonstrated that the short-term memory formation in rats is also observable in the inhibitory 
avoidance paradigm akin to the Morris water maze test. According to our interpretation, the 
effective doses of the agonists enhanced the consolidation of this short-term memory.  The 
role of DA and its receptors in inhibitory avoidance learning and in the related memory 
consolidation processes have been generally proven in different brain areas.  In mouse, 
microinjection of the D1 DA receptor antagonist SCH23390 and the D2 DA receptor 
antagonista Sulpiride in the core region of the NAC dose-dependently prevented the memory 
consolidation, while in the shell region of the NAC only the Sulpiride had a similar effect 
[16]. The memory consolidation in inhibitory avoidance learning requires the co-activation of 
the DA receptors of the NAC shell region and of the basolateral AMY [15]. The SCH23390, 
but not the Sulpiride microinjected into the chick CPU impairs the inhibitory avoidance 
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learning and memory processes [61]. In inhibitory avoidance learning paradigm the D1 DA 
receptor antagonist SCH23390 microinjected into the anterolateral prefrontal and the 
posteroparietal cortices, as well as, into the CA1 region of the HPC before conditioning 
inhibits the acquisition [62]. After conditioning - the same substance - applied in the CA1 
region of the HPC enhances the formation of the short-term memory, however, in the 
anterolateral prefrontal and the entorhinal cortices impaires the long-term memory [62]. In the 
same paradigm the SCH23390 in the anteromedial precentral PFC prevents the memory 
consolidation [14]. Additional findigs, partly inconsistent with the previous results, are that 
the 6-OHDA lesion of the AMY impairs the active avoidace learnig, but interestingly slightly 
improves the passive (inhibitory) form of it [63]. Furthermore, DA administered into the NAC 
before conditioning impairs the inhibitory avoidance learning [64]. Our criticism against these 
two latter experiments are identical with those decribed in the discussion of the results of the 
Morris water maze test. Accordingly, in case of the absent DMI pretreatment the 6-OHDA 
lesion is not specific to the DA-ergic terminals, namely it will affect the noradrenergic fibers 
as well, and DA administration prior to the conditioning can influence both the motivational 
and motor processes interfering with the learning/memory consolidation effects.  
The D1 DA receptor antagonist SCH23390 and the D2 DA receptor antagonist 
Sulpiride pretreatment confirmed that the SKF38393 activated the D1 DA receptors, while the 
Quinpirole the D2 DA receptors. The antagonists applied by itself did not affect significantly 
the memory consolidation and its retention.  
In summary the activation of the VP D1 and D2 DA receptors enhances the memory 
consolidation and the long-term stability of the formed memory in inhibitory avoidance 
learning.   
 
5.3.  Evaluation of the results of the place preference test 
 
 
The place preference test is applied to detect the reinforcing (rewarding or punishing) 
effect of different chemical substances [65, 66], which makes it important to investigate the 
addictive effect of different drugs. In our experiments neither the D1, nor the D2 DA receptor 
agonist treatment evoked place preference. It is well known that cocaine microinjected into 
the VP induces place preference [38] by significantly increasing the DA level in the VP. The 
cocaine-induced place preference can be eliminated by 6-OHDA lesion of the VP [39], and 
similar result can be obtained by application of the opiate antagonist naloxone [67]. Based on 
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these findings the place preference inducing effect of cocaine is realised via DA-ergic and 
opiate-ergic mechanisms in a way that none of these systems’ activity is satisfactory in itself, 
but both are necessary for the formation of the place preference. This latter requires the 
fulfillment of two conditions in the experimental animals: the administered substance 1.) has 
to possess rewarding/positive reinforcing effect and 2.) this effect has to be consolidated in 
the central nervous system. Both in the Morris water maze test and in the open field based 
place preference paradigm the spatial learning of the experimental animals is necessary to find 
the platform in the former or the treatment quadrant in the latter. Therefore, it can be 
supposed that certain doses of the agonists fulfilled the consolidation condition in the place 
preference test, similarly to the Morris water maze test, but the place preference did not 
develop because of the absent rewarding effect of the agonists. It is well confirmed by 
experimental data that 1.) the primary site of the DA rewarding effect is the NAC [10, 68-72],  
2.) the rewarding effect of cocaine develops not, or only partly via the DA system [73-76]. 
Separability of the rewarding and the consolidation effects has been shown by the 
experiments, in which the influence of D1 and D2 DA receptors on morfine induced place 
preference was investigated in the AMY. In both cases place preference was not induced by 
the activation of the DA receptors in itself, however, DA receptor activation amplified the 
morphine induced place preference [77, 78].  
  In addition to the classic parameter of the place preference - the time spent in the 
treatment quadrant - the number of the entries into the treatment quadrant was measured, 
which can reflect the orientation response for the signals of the treatment quadrant.  Our 
results showed that in case of the D1 DA receptor agonist there was no significant difference 
among the groups, while the 1.0 µg dose of the D2 DA agonist increased the number of the 
entries. Based on the analysis of the locomotor activity this elevation was not due to the 
treatment quadrant-specific orientation, but rather to the increased locomotor activity. It was 
assumed that the observed increase in locomotor activity during the test is identical with the 
phenomenon of the conditioned locomotor activity [65, 79]. To justify this assumption the 
locomotor activity of the rats was measured during the conditioning trials, (although the 
results obtained in open field paradigm by Gong and Neil were reproduced considering the 
effect of the Quinpirole [80]) but the results did not support our previous assumption. The 1.0 
µg dose of the agonist did not produce an increased locomotor activity, so this effect could 
not be consolidated in the nervous sytem of the rats. So this option had to be rejected, the 
interpretation of the increased locomotor activity during the test caused by the 1.0 µg 
Quinpirole treatment requires data of further experiments.  
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In summary neither the D1 DA receptor agonist SKF38393, nor the D2 DA agonist 
Quinpirole microinjected into the VP induce place preference.  
 
6. Summary 
 
 
The followings were confirmed in our experiments:  
 
 
1. In the Morris water maze paradigm investigating the spatial learing processes 
a) the 0.1 and 1.0 µg doses of the D1 DA receptor agonist SKF38393, as well as 
b) the 1.0 and 5.0 µg doses of the D2 DA receptor agonist Quinpirole  
microinjected into the VP accelerate the memory consolidation and enhance the stability of 
the formed memory against extinction.  
 
2. In the inhibitory avoidance paradigm investigating the learning processes related to the 
negative reinforcement  
a) the D1 DA receptor agonist SKF38393 dose-dependently, as well as 
b) the 0.1 µg  dose of the D2 DA receptor agonist Quinpirole  
microinjected into the VP  enhance the memory consolidation and the long-term stability of 
the formed memory.  
 
3.  In both paradigms it was confirmed that the  
a) effect of SKF38393 is eliminated by the D1 DA receptor selective antagonist SCH23390 
pretreatment, and 
b) effect of Quinpirole is eliminated by the D2 DA receptor selective antagonist Sulpiride 
pretreatment  
in the VP.  
 
4. The SCH23390 applied by itself was ineffective in both paradigms, however the Sulpiride 
applied by itself prevented the learning processes in a long-run and general way in the Morris 
water maze paradigm, while in the inhibitory avoidance paradigm it was ineffective. 
 
5. In both paradigms formation of the short-term memory was demonstrated, which could be 
consolidated by the agonists microinjected into the VP.  
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6. Neither the D1 DA receptor agonist SKF38393, nor the D2 DA receptor agonist Quinpirole 
microinjected into the VP induce place preference.  
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